Blogs about IVGN - Stockpickr! Your Source for Stock Ideas

Blogs about IVGN

Blogs	Description	Date Updated
Cohen's SAC Boosts Stake in Invitrogen (IVGN) to 6.9%	In an amended 13D filing after the close on Invitrogen Corp. (Nasdaq: IVGN), Steven Cohen's SAC Capital disclosed a 6.9% (6,171,830 shares) stake in the company. This is up from the 5.2% stake Cohen showed in the original 13D filing in July.In the original filing, SAC said, "Based on the information that is publicly available, the Reporting Persons are supportive of the proposed merger with Applera (NYSE: ABI)."In June, Invitrogen agreed to acquire Applera's Applied Biosystems Group (NYSE: ABI)...	July 29, 2008
Wednesday's Upgrades and Downgrades	UPGRADESCenturytel (CTL)- Stanford Research Hold » Buy Cheesecake Factory (CAKE)- Wedbush Morgan Hold » Buy Global Industries (GLBL)- CapitalOne southcoast Add » Strong Buy Pioneer Natural (PXD)- BMO Capital Markets Market Perform » Outperform Raytheon (RTN)- JP Morgan Neutral » Overweight RC2 (RCRC)- Piper Jaffray Neutral » Buy Key Energy (KEG)- RBC Capital Mkts Sector Perform » Outperform UST Inc (UST)- UBS Neutral » Buy Invitrogen (IVGN)- JP Morgan ...	June 25, 2008
Analyst upgrades: PSD, RCRC and MVL	Filed under: Analyst upgrades and downgrades, Marvel Entertainment (MVL)MOST NOTEWORTHY: Puget Energy, RC2 Corp and Marvel Entertainment were today's noteworthy upgrades: Baird upgraded Puget Energy (NYSE: PSD) to Outperform from Neutral citing valuation on a stand-alone basis and sees additional upside if the merger with Macquarie is approved this fall. Piper upgraded shares of RC2 Corp (NASDAQ: RCRC) to Buy from Neutral following the Children's Publishing Division acquisition as ...	June 24, 2008
Baby Teeth, Stem Cells, and Stocks	What do baby teeth, stem cells and stocks have in common? The National Institute of Health has discovered that strong stem cells can be found in baby teeth, and there are stocks of several companies involved in stem cell research. Last month, a dental practice management company in Houston announced that they will offer a service of storing stem cells from baby teeth. Extensive research is being done to utilize stem cells for gene therapy and the treatment of multiple sclerosis, Parkinson’s di...	June 18, 2008
Analyst downgrades: VZ, T, IVGN, GE, OMX, RYAAY, WBMD	Filed under: Analyst reports, Analyst upgrades and downgrades, General Electric (GE), AT and T (T), Verizon Communications (VZ), OfficeMax Inc (OMX)MOST NOTEWORTHY: Verizon, AT&T, Invitrogen and General Electric were today's noteworthy downgrades: UBS downgraded Verizon (NYSE: VZ) and AT&T (NYSE: T) to Neutral from Buy citing the weak economy and increased wireless competition. Banc of America downgraded shares of Invitrogen (NASDAQ: IVGN) to Neutral from Buy as the company...	June 16, 2008
Monday's Upgrades and Downgrades	UPGRADESInvitrogen (IVGN)- First Analysis Sec Equal-Weight » Overweight Hercules Offshore (HERO)- CapitalOne southcoast Neutral » Add Apollo Group (APOL)- First Analysis Sec Equal-Weight » Overweight Yahoo! (YHOO)- Stifel Nicolaus Hold » Buy Continental Air (CAL)- Soleil Hold » Buy Partner Comms (PTNR)- UBS Neutral » Buy Yahoo! (YHOO)- Soleil Sell » Hold Petro-Canada (PCZ)- Banc of America Sec Neutral » Buy Old Dominion (ODFL)- Robert W. Baird Neutral ...	June 15, 2008
Fast Money Recap	Word On The Street WORD VIDEO HERE Apple Talk Najarian mentioned that the market ignored Apple (AAPL) 4% slide today. He feels the stock is falling because rumors are swirling that CEO Steve Jobs has some health issue. Macke said if Jobs leaves for any reason Apple is in big trouble. Microsoft Aftermath The traders spoke with Jeff Lindsay of Stanford Bernstein about the news that Microsoft (MSFT) and Yahoo (YHOO) merger talks have completely fallen apart. Lindsay says the big loser is Yahoo and ...	June 12, 2008
Downwared Volume Surge: Invitrogen (IVGN, ABI)	Invitrogen Corp. (NASDAQ: IVGN) is seeing a surge in trading volume this morning, and the reason is a $6.7 Billion acquisition of Applera’s Applied Biosystems Group (NYSE: ABI). We have already seen over 650,000 shares trade hands at 9:20 AM EST and the average daily volume is 1.3 million shares. Shares are down right around $39.00 pre-market, while the 52-week trading range is $35.12 to $49.58....	June 12, 2008
Invitrogen (IVGN): A 'split' candidate buy	Filed under: Newsletters, Stocks to BuyBuying only stocks announcing splits, Neil Macneale has developed a leading long-term track record. His latest buy in his 2-for-1 newsletter is biotechnology research products firm Invitrogen (NASDAQ: IVGN). "Wow, investing today is like riding a ping-pong ball; last month I was feeling quite glum about the market and cautioned that we were in for an extended period of below normal portfolio growth. "That may still be true, but now, as we go to press, th...	June 10, 2008
Sageview Capital - Batting One Thousand	This morning, a stock on our activist list, Guitar Center (Nasdaq: GTRC), announced they would be acquired by private equity firm Bain Capital for $63 per share, a 26% premium to yesterday's close.In September of 2006 we noted that newcomer Sageview Capital, founded by former KKR stars Ned Gilhuly and Scott Stuart, had built a 6.46% stake in the company.Sageview had a cost basis of around $39.70 per share, indicating a potential profit of 59%. Not bad for your first investment!The only other sto...	June 27, 2007

Enter search text here: